| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 16.540 | 28.129 | 63.388 | 113.927 | 162.927 | 200.897 | 276.146 | 326.721 |
| Total Income - EUR | - | - | 16.996 | 36.043 | 71.748 | 120.038 | 168.001 | 205.981 | 281.215 | 331.758 |
| Total Expenses - EUR | - | - | 9.585 | 34.466 | 63.999 | 95.660 | 144.996 | 180.425 | 237.126 | 264.477 |
| Gross Profit/Loss - EUR | - | - | 7.411 | 1.577 | 7.749 | 24.378 | 23.005 | 25.556 | 44.089 | 67.282 |
| Net Profit/Loss - EUR | - | - | 7.069 | 1.298 | 7.115 | 23.534 | 21.408 | 23.587 | 41.659 | 58.950 |
| Employees | - | - | 3 | 3 | 5 | 5 | 5 | 6 | 4 | 5 |
Check the financial reports for the company - Edna Queen Gyn Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 49.722 | 42.732 | 36.714 | 30.740 | 25.233 | 19.490 | 27.987 | 69.872 |
| Current Assets | - | - | 47.838 | 6.932 | 16.388 | 38.157 | 22.862 | 29.586 | 46.512 | 56.393 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 43.782 | 1.477 | 3.858 | 3.271 | 17.709 | 15.229 | 17.521 | 984 |
| Cash | - | - | 4.056 | 5.455 | 12.529 | 34.886 | 5.153 | 14.357 | 28.991 | 55.409 |
| Shareholders Funds | - | - | 7.112 | 8.280 | 15.234 | 38.479 | 21.795 | 23.720 | 55.199 | 113.231 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 47.122 | 4.227 | 6.697 | 5.007 | 6.506 | 10.570 | 9.614 | 8.427 |
| Income in Advance | - | - | 43.326 | 37.158 | 31.170 | 25.411 | 19.794 | 14.786 | 9.687 | 4.607 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Edna Queen Gyn Srl